Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Share:
Related VRX
Benzinga's M&A Chatter for Thursday August 20, 2015
Valeant CEO Reveals Plans For Female Libido Enhancement Medication Addyi
Acelity Files To Float, But Is It Secretly Seeking A Buyer? (Seeking Alpha)
Related AGN
Allergan Gedeon Richter Plc. to Present Data from Cariprazine Trials at ECNP Annual Meeting in Amsterdam
13F Recap: The Most Popular (And Unpopular) Stocks Of Q2
Will Clinical Trial Firm Icon Pass This Market Test? (Investor's Business Daily)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors

 

Related Articles (AGN + VRX)

Get Benzinga's Newsletters